ANIX Butterfly Strategy
ANIX (Anixa Biosciences, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the treatment of ovarian cancer; and the discovery and development of anti-viral drug candidates for the treatment of COVID-19 focused on inhibiting certain protein functions of the virus. Its vaccine programs comprise the development of a vaccine against triple negative breast cancer; and a preventative vaccine against ovarian cancer. The company is also developing immuno-therapy drugs against cancer. It has a collaboration agreement with MolGenie GmbH to discover and develop anti-viral drug candidates against COVID-19. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018.
ANIX (Anixa Biosciences, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $97.2M, a beta of 0.65 versus the broader market, a 52-week range of 2.44-5.46, average daily share volume of 118K, a public-listing history dating back to 1983, approximately 5 full-time employees. These structural characteristics shape how ANIX stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.65 indicates ANIX has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a butterfly on ANIX?
A long call butterfly buys one lower-strike call, sells two ATM calls, and buys one higher-strike call, paying a small net debit for a defined-risk position that maxes out if the underlying pins the middle strike at expiration.
Current ANIX snapshot
As of May 15, 2026, spot at $2.85, ATM IV 31.70%, IV rank 1.95%, expected move 9.09%. The butterfly on ANIX below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this butterfly structure on ANIX specifically: ANIX IV at 31.70% is on the cheap side of its 1-year range, which favors premium-buying structures like a ANIX butterfly, with a market-implied 1-standard-deviation move of approximately 9.09% (roughly $0.26 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated ANIX expiries trade a higher absolute premium for lower per-day decay. Position sizing on ANIX should anchor to the underlying notional of $2.85 per share and to the trader's directional view on ANIX stock.
ANIX butterfly setup
The ANIX butterfly below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With ANIX near $2.85, the first option leg uses a $2.71 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed ANIX chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 ANIX shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $2.71 | N/A |
| Sell 2 | Call | $2.85 | N/A |
| Buy 1 | Call | $2.99 | N/A |
ANIX butterfly risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals the wing width minus net debit times 100 (reached when the underlying pins the middle strike); max loss equals the net debit times 100. Two breakevens at lower-wing plus debit and upper-wing minus debit.
ANIX butterfly payoff curve
Modeled P&L at expiration across a range of underlying prices for the butterfly on ANIX. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use butterfly on ANIX
Butterflies on ANIX are pinning bets - traders use them when they expect ANIX to settle near a specific level at expiration (often the prior close, a round number, or the max-pain strike) and want defined-risk exposure to that outcome.
ANIX thesis for this butterfly
The market-implied 1-standard-deviation range for ANIX extends from approximately $2.59 on the downside to $3.11 on the upside. A ANIX long call butterfly is a pinning play: it pays maximum at the middle strike if ANIX settles there at expiration, with the wing legs capping both the cost and the maximum loss to the net debit. Current ANIX IV rank near 1.95% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on ANIX at 31.70%. As a Healthcare name, ANIX options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to ANIX-specific events.
ANIX butterfly positions are structurally neutral / pin (limited-risk, limited-reward); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. ANIX positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move ANIX alongside the broader basket even when ANIX-specific fundamentals are unchanged. Always rebuild the position from current ANIX chain quotes before placing a trade.
Frequently asked questions
- What is a butterfly on ANIX?
- A butterfly on ANIX is the butterfly strategy applied to ANIX (stock). The strategy is structurally neutral / pin (limited-risk, limited-reward): A long call butterfly buys one lower-strike call, sells two ATM calls, and buys one higher-strike call, paying a small net debit for a defined-risk position that maxes out if the underlying pins the middle strike at expiration. With ANIX stock trading near $2.85, the strikes shown on this page are snapped to the nearest listed ANIX chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are ANIX butterfly max profit and max loss calculated?
- Max profit equals the wing width minus net debit times 100 (reached when the underlying pins the middle strike); max loss equals the net debit times 100. Two breakevens at lower-wing plus debit and upper-wing minus debit. For the ANIX butterfly priced from the end-of-day chain at a 30-day expiry (ATM IV 31.70%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a ANIX butterfly?
- The breakeven for the ANIX butterfly priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current ANIX market-implied 1-standard-deviation expected move is approximately 9.09%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a butterfly on ANIX?
- Butterflies on ANIX are pinning bets - traders use them when they expect ANIX to settle near a specific level at expiration (often the prior close, a round number, or the max-pain strike) and want defined-risk exposure to that outcome.
- How does current ANIX implied volatility affect this butterfly?
- ANIX ATM IV is at 31.70% with IV rank near 1.95%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.